Eagle Asset Management Inc. Buys Shares of 105,316 Integer Holdings Co. (NYSE:ITGR)

Eagle Asset Management Inc. bought a new position in shares of Integer Holdings Co. (NYSE:ITGR - Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 105,316 shares of the medical equipment provider's stock, valued at approximately $14,403,000. Eagle Asset Management Inc. owned approximately 0.31% of Integer as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also recently bought and sold shares of ITGR. Contravisory Investment Management Inc. increased its position in shares of Integer by 55.9% in the third quarter. Contravisory Investment Management Inc. now owns 223 shares of the medical equipment provider's stock worth $29,000 after acquiring an additional 80 shares in the last quarter. Xponance Inc. increased its holdings in Integer by 4.9% in the 2nd quarter. Xponance Inc. now owns 2,112 shares of the medical equipment provider's stock valued at $245,000 after purchasing an additional 99 shares in the last quarter. Azzad Asset Management Inc. ADV raised its position in Integer by 0.9% in the third quarter. Azzad Asset Management Inc. ADV now owns 11,572 shares of the medical equipment provider's stock valued at $1,504,000 after purchasing an additional 107 shares during the period. GAMMA Investing LLC lifted its stake in shares of Integer by 60.9% during the second quarter. GAMMA Investing LLC now owns 375 shares of the medical equipment provider's stock worth $43,000 after purchasing an additional 142 shares in the last quarter. Finally, Envestnet Portfolio Solutions Inc. boosted its position in shares of Integer by 3.6% in the second quarter. Envestnet Portfolio Solutions Inc. now owns 5,948 shares of the medical equipment provider's stock worth $689,000 after buying an additional 205 shares during the period. Hedge funds and other institutional investors own 99.29% of the company's stock.

Integer Stock Up 1.6 %

Shares of Integer stock traded up $2.23 during trading on Friday, reaching $138.11. The company had a trading volume of 181,641 shares, compared to its average volume of 277,849. The company has a debt-to-equity ratio of 0.67, a quick ratio of 2.09 and a current ratio of 3.28. Integer Holdings Co. has a fifty-two week low of $84.75 and a fifty-two week high of $140.91. The firm's fifty day moving average is $130.22 and its 200-day moving average is $123.50. The company has a market cap of $4.63 billion, a price-to-earnings ratio of 42.63, a price-to-earnings-growth ratio of 1.95 and a beta of 1.09.

Integer (NYSE:ITGR - Get Free Report) last announced its quarterly earnings data on Thursday, October 24th. The medical equipment provider reported $1.43 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.36 by $0.07. The firm had revenue of $431.42 million for the quarter, compared to analysts' expectations of $440.59 million. Integer had a return on equity of 11.63% and a net margin of 6.70%. Integer's revenue for the quarter was up 8.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.27 earnings per share. On average, analysts anticipate that Integer Holdings Co. will post 5.34 EPS for the current year.

Analyst Ratings Changes

Several equities research analysts recently commented on ITGR shares. Piper Sandler reiterated an "overweight" rating and set a $140.00 target price (up from $125.00) on shares of Integer in a report on Friday, October 25th. Benchmark lifted their price objective on shares of Integer from $130.00 to $140.00 and gave the company a "buy" rating in a research note on Monday, October 21st. Citigroup upped their target price on shares of Integer from $124.00 to $130.00 and gave the company a "neutral" rating in a research note on Tuesday, October 1st. Bank of America lifted their price target on shares of Integer from $135.00 to $145.00 and gave the stock a "buy" rating in a research note on Tuesday, October 1st. Finally, KeyCorp upped their price objective on shares of Integer from $139.00 to $144.00 and gave the company an "overweight" rating in a research report on Tuesday, October 15th. One equities research analyst has rated the stock with a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $139.75.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.